Up a level |
Miller, Jennifer L, Gevers, Evelien, Bridges, Nicola, Yanovski, Jack A, Salehi, Parisa, Obrynba, Kathryn S, Felner, Eric I, Bird, Lynne M, Shoemaker, Ashley H, Angulo, Moris et al (show 9 more authors)
(2023)
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 108 (7).
pp. 1676-1685.
Miller, Jennifer L, Gevers, Evelien, Bridges, Nicola ORCID: 0000-0002-2915-4877, Yanovski, Jack A ORCID: 0000-0001-8542-1637, Salehi, Parisa, Obrynba, Kathryn S, Felner, Eric I, Bird, Lynne M, Shoemaker, Ashley H, Angulo, Moris et al (show 14 more authors)
(2024)
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.
Obesity (Silver Spring, Md.), 32 (2).
pp. 252-261.
Hawcutt, DB ORCID: 0000-0002-8120-6507, Bellis, J, Price, V, Povall, A, Newland, P, Richardson, P, Peak, M ORCID: 0000-0003-1909-3211 and Blair, J
(2017)
Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height.
PLoS One, 12 (7).
e0181567-.